...
首页> 外文期刊>The Journal of biological chemistry >New Hyperekplexia Mutations Provide Insight into Glycine Receptor Assembly, Trafficking, and Activation Mechanisms
【24h】

New Hyperekplexia Mutations Provide Insight into Glycine Receptor Assembly, Trafficking, and Activation Mechanisms

机译:新的Hyperekplexia突变提供对甘氨酸受体组装,贩运和激活机制的洞察力

获取原文

摘要

Hyperekplexia is a syndrome of readily provoked startle responses, alongside episodic and generalized hypertonia, that presents within the first month of life. Inhibitory glycine receptors are pentameric ligand-gated ion channels with a definitive and clinically well stratified linkage to hyperekplexia. Most hyperekplexia cases are caused by mutations in the α1 subunit of the human glycine receptor (hGlyR) gene (GLRA1). Here we analyzed 68 new unrelated hyperekplexia probands for GLRA1 mutations and identified 19 mutations, of which 9 were novel. Electrophysiological analysis demonstrated that the dominant mutations p.Q226E, p.V280M, and p.R414H induced spontaneous channel activity, indicating that this is a recurring mechanism in hGlyR pathophysiology. p.Q226E, at the top of TM1, most likely induced tonic activation via an enhanced electrostatic attraction to p.R271 at the top of TM2, suggesting a structural mechanism for channel activation. Receptors incorporating p.P230S (which is heterozygous with p.R65W) desensitized much faster than wild type receptors and represent a new TM1 site capable of modulating desensitization. The recessive mutations p.R72C, p.R218W, p.L291P, p.D388A, and p.E375X precluded cell surface expression unless co-expressed with α1 wild type subunits. The recessive p.E375X mutation resulted in subunit truncation upstream of the TM4 domain. Surprisingly, on the basis of three independent assays, we were able to infer that p.E375X truncated subunits are incorporated into functional hGlyRs together with unmutated α1 or α1 plus β subunits. These aberrant receptors exhibit significantly reduced glycine sensitivity. To our knowledge, this is the first suggestion that subunits lacking TM4 domains might be incorporated into functional pentameric ligand-gated ion channel receptors.
机译:Hyperekplexia是一种令人挑剔的惊人反应的综合症,以及透过透明和广义过度的高渗,在生命的第一个月内容。抑制性甘氨酸受体是五聚体配体门控离子通道,其具有明确的且临床上分层的粘合性与过腹血糖肝脏。大多数HyperekplexIa病例是由人甘氨酸受体(HglyR)基因(Glra1)的α1亚基的突变引起的。在这里,我们分析了Glra1突变的68次新的无关的Hyperkplexia并确定了19个突变,其中9个突变是新的。电生理学分析证明了P.Q226E,P.V280M和P.R414H的显性突变诱导自发性通道活性,表明这是H​​glyr病理生理学中的重复机制。 P.Q226E,在TM1的顶部,最有可能通过增强的静电吸引力诱导滋补激活于TM2顶部的P.R271,表明通道激活的结构机制。掺入p.p230s(与p.r65w的杂合)的受体比野生型受体更快地脱敏,并且代表能够调节脱敏的新型TM1位点。除非用α1野生型亚基共表达,否则隐性突变P.R72C,P.R218W,P.L291P,P.D388A和P.E375X排除细胞表面表达。隐性p.e375x突变导致TM4结构域上游的亚基截短。令人惊讶的是,在三个独立的测定的基础上,我们能够推断P.e375x截短的亚基与未换α1或α1加上β亚基一起掺入功能性hglyr。这些异常受体表现出显着降低的甘氨酸敏感性。据我们所知,这是缺乏TM4结构域的亚基的第一个建议可以掺入功能性五聚体配体门通道受体中。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号